Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adjuvant chemotherapy for completely resected IIA-IIIA non-small cell lung cancer: compliance to guidelines, safety and efficacy in real-life practice.
Désage AL, Tissot C, Bayle-Bleuez S, Muron T, Deygas N, Grangeon-Vincent V, Monange B, Torche F, Vercherin P, Kaczmarek D, Tiffet O, Forest F, Vergnon JM, Bouleftour W, Fournel P. Désage AL, et al. Among authors: muron t. Transl Lung Cancer Res. 2022 Dec;11(12):2418-2437. doi: 10.21037/tlcr-22-345. Transl Lung Cancer Res. 2022. PMID: 36636405 Free PMC article.
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).
Lièvre A, Turpin A, Ray-Coquard I, Le Malicot K, Thariat J, Ahle G, Neuzillet C, Paoletti X, Bouché O, Aldabbagh K, Michel P, Debieuvre D, Canellas A, Wislez M, Laurent L, Mabro M, Colle R, Hardy-Bessard AC, Mansi L, Colomba E, Bourhis J, Gorphe P, Pointreau Y, Idbaih A, Ursu R, Di Stefano AL, Zalcman G, Aparicio T; GCO-002 CACOVID-19 collaborators/investigators. Lièvre A, et al. Eur J Cancer. 2020 Dec;141:62-81. doi: 10.1016/j.ejca.2020.09.035. Epub 2020 Oct 8. Eur J Cancer. 2020. PMID: 33129039 Free PMC article.
FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: The PRODIGE 59-FFCD 1707-DURIGAST Randomized Clinical Trial.
Tougeron D, Dahan L, Evesque L, Le Malicot K, El Hajbi F, Aparicio T, Bouché O, Bonichon Lamichhane N, Chibaudel B, Angelergues A, Bodere A, Phelip JM, Mabro M, Kaluzinski L, Petorin C, Breysacher G, Rinaldi Y, Zaanan A, Smith D, Gouttebel MC, Perret C, Etchepare N, Emile JF, Sanfourche I, Di Fiore F, Lepage C, Artru P, Louvet C; PRODIGE 59-FFCD 1707-DURIGAST Investigators/Collaborators. Tougeron D, et al. JAMA Oncol. 2024 Apr 4. doi: 10.1001/jamaoncol.2024.0207. Online ahead of print. JAMA Oncol. 2024. PMID: 38573643
Local treatment in the setting of de novo metastatic rectal cancer: reappraisal of prognostic factors.
Vial N, Langrand-Escure J, Diao P, Garcia MA, Jmour O, Ben Mrad M, Guy JB, Abid W, Sotton S, Espenel S, Guillaume E, Rehailia-Blanchard A, Pigné G, Trone JC, Rancoule C, Kaczmarek D, Muron T, Le Roy B, Phelip JM, Vallard A, Magné N. Vial N, et al. Among authors: muron t. Swiss Med Wkly. 2021 Dec 15;151:w30034. doi: 10.4414/smw.2021.w30034. eCollection 2021 Dec 6. Swiss Med Wkly. 2021. PMID: 34964579 Free article.
FIP1L1-PDGFRA-Associated Hypereosinophilic Syndrome as a Treatable Cause of Watershed Infarction.
Tennenbaum J, Groh M, Venditti L, Campos-Gazeau F, Chalayer E, De Broucker T, Hamidou M, Hunault M, Lyoubi A, Meunier R, Muron T, Sène D, Slama B, Guidoux C, Lefèvre G, Kahn JE, Denier C, Rohmer J. Tennenbaum J, et al. Among authors: muron t. Stroke. 2021 Oct;52(10):e605-e609. doi: 10.1161/STROKEAHA.121.034191. Epub 2021 Jul 26. Stroke. 2021. PMID: 34304603
Effectiveness of a nurse-led telephone follow-up in the therapeutic management of patients receiving oral antineoplastic agents: a randomized, multicenter controlled trial (ETICCO study).
Bouleftour W, Muron T, Guillot A, Tinquaut F, Rivoirard R, Jacquin JP, Saban-Roche L, Boussoualim K, Tavernier E, Augeul-Meunier K, Collard O, Mery B, Pupier S, Oriol M, Bourmaud A, Fournel P, Vassal C. Bouleftour W, et al. Among authors: muron t. Support Care Cancer. 2021 Aug;29(8):4257-4267. doi: 10.1007/s00520-020-05955-3. Epub 2021 Jan 7. Support Care Cancer. 2021. PMID: 33409726 Clinical Trial.
Epidemiology, clinical picture and long-term outcomes of FIP1L1-PDGFRA-positive myeloid neoplasm with eosinophilia: Data from 151 patients.
Rohmer J, Couteau-Chardon A, Trichereau J, Panel K, Gesquiere C, Ben Abdelali R, Bidet A, Bladé JS, Cayuela JM, Cony-Makhoul P, Cottin V, Delabesse E, Ebbo M, Fain O, Flandrin P, Galicier L, Godon C, Grardel N, Guffroy A, Hamidou M, Hunault M, Lengline E, Lhomme F, Lhermitte L, Machelart I, Mauvieux L, Mohr C, Mozicconacci MJ, Naguib D, Nicolini FE, Rey J, Rousselot P, Tavitian S, Terriou L, Lefèvre G, Preudhomme C, Kahn JE, Groh M; CEREO and GBMHM collaborators. Rohmer J, et al. Am J Hematol. 2020 Nov;95(11):1314-1323. doi: 10.1002/ajh.25945. Epub 2020 Sep 19. Am J Hematol. 2020. PMID: 32720700 Free article. Clinical Trial.
Intensification of induction chemotherapy before consolidation chemoradiotherapy improves progression-free survival and time without treatment in patients with locally advanced pancreatic cancers.
Williet N, Di Bernardo T, Vernet C, Roche LS, Muron T, Roblin X, Magne N, Phelip JM. Williet N, et al. Among authors: muron t. Oncotarget. 2018 Aug 10;9(62):31999-32009. doi: 10.18632/oncotarget.25877. eCollection 2018 Aug 10. Oncotarget. 2018. PMID: 30174792 Free PMC article.
Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey.
Langrand-Escure J, Diao P, Garcia MA, Wang G, Guy JB, Espenel S, Guillaume E, Rehailia-Blanchard A, Pigné G, de Laroche G, Kaczmarek D, Muron T, Porcheron J, Phelip JM, Vallard A, Magné N. Langrand-Escure J, et al. Among authors: muron t. Sci Rep. 2018 Jul 16;8(1):10708. doi: 10.1038/s41598-018-29040-2. Sci Rep. 2018. PMID: 30013090 Free PMC article.
Outcomes prediction in pre-operative radiotherapy locally advanced rectal cancer: leucocyte assessment as immune biomarker.
Vallard A, Garcia MA, Diao P, Espenel S, de Laroche G, Guy JB, Mrad MB, Rancoule C, Kaczmarek D, Muron T, Pigné G, Porcheron J, Peoc'h M, Phelip JM, Langrand-Escure J, Magné N. Vallard A, et al. Among authors: muron t. Oncotarget. 2018 Apr 27;9(32):22368-22382. doi: 10.18632/oncotarget.25023. eCollection 2018 Apr 27. Oncotarget. 2018. PMID: 29854285 Free PMC article.
19 results